Urology Doctors in Peoria, IL Accepting Medicare

9 Urology doctors found. Showing 1 - 9

Jubilee Phan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1001 Main St Ste 400, Peoria, IL 61606 Phone: 309-308-0920    Fax: 309-308-0930

Dr. Robert Stuart, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 7309 N Knoxville Ave, Peoria, IL 61614 Phone: 309-692-9898    Fax: 309-692-9055

Dr. James Nicholas Kenny Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 200 E Pennsylvania Ave, Suite 201, Peoria, IL 61603 Phone: 309-655-7700    Fax: 309-624-8790

Dr. Churphena Reid, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1001 Main St, Suite 201, Peoria, IL 61606 Phone: 309-495-0282    Fax: 309-495-0298

Dr. Giovanni Colombo, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7309 N Knoxville Ave, Peoria, IL 61614 Phone: 309-692-9898    Fax: 309-692-9055

Dr. Ted A Solomon, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 200 E Pennsylvania Ave, Suite 201, Peoria, IL 61603 Phone: 309-655-7700    Fax: 309-624-8790

Dr. Jose M Hernandez, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 7309 N Knoxville Ave, Peoria, IL 61614 Phone: 309-692-9898    Fax: 309-692-9055

Dr. Joseph Banno, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7309 N Knoxville Ave, Peoria, IL 61614 Phone: 309-692-9898    Fax: 309-692-9055

Dr. Ali El Ghazzaoui, MD Urology - Pediatric Urology Medicare: Medicare Enrolled Practice Location: 420 Ne Glen Oak Ave, Peoria, IL 61603 Phone: 647-404-7544

News Archive

Companies focus on wellness programs to help bottom lines

Corporations view employee obesity and smoking as two things driving up their health care costs. Therefore, many businesses are taking steps toward wellness programs and incentives.

New website launched provides details on breast cancer risks faced by younger women

A website launched to coincide with National Breast Cancer Awareness Month, at www.earlyactawareness.org, provides a powerful focal point for efforts to pass the EARLY Act.

Trubion announces Pfizer's decision to discontinue development of TRU-015 for RA

Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.

MedVentive announces completion of oversubscribed Series C fundraising

MedVentive announced today the completion of its oversubscribed Series C fundraising. The $10 million in capital is targeted to fuel the company's next phase of product innovation, which will expand the ability of its technology to reduce costs to purchasers while improving the quality of care to patients.

Read more Medical News

› Verified 1 days ago